Clinical Trials Logo

Clinical Trial Summary

The use of non-invasive intracranial pressure monitoring, including intracranial pressure pulse morphology in patients with COVID-19, could calculate possible components associated with the presence of neurological symptoms in these patients, in addition to being a tool with the potential to monitor the repercussion of MV at cerebral compliance patient patients. In addition, it is likely that patients with COVID-19 also have cerebral embolization more frequently than healthy patients, which is justified by transcranial doppler ultrasound assessment. The aim of the study is to monitor this brain pressure using a non-invasive method of monitoring, with a helmet-like system in place, for 1 hour for 7 consecutive days. There will be no associated invasive procedure of any kind. Monitoring will be done by the criteria themselves, no place where the patient and the mandatory volunteer. Another objective is to capture signs of microembolisms (small strokes that have not yet manifested) by performing a doppler ultrasound on the head with a helmet also for 1 hour, in a single evaluation. The study population will include inpatients with COVID-19 infection. The control group will be in patients who do not have Covid-19. The control group will consist of people with similar characteristics and who have not recovered. Patients who meet the inclusion criteria incorporated into the monitoring with a non-invasive intracranial pressure device for 1 hour during hospitalization (Brain4Care® device approved by ANVISA), being monitored for up to seven days, in addition to monitoring for 1 hour with a transcranial doppler ultrasound helmet DWL® in a single assessment. There will be no invasive procedures or other equipment used without due knowledge by Organs competent bodies. It does not collect collection or retention of any biological material.


Clinical Trial Description

INTRODUCTION: The Coronavirus Disease 2019 (COVID-19) is an infectious disease transmitted one person to another mainly from cough and sneeze aerosols as well as from contaminated surfaces. The most common respiratory symptoms are dry cough, fever, and dyspnea, but the Severe Respiratory Acute Syndrome (SARS) can be installed increasing disease´s mortality. In addition, neurological symptoms have been described according the increase of severity and age. Changes of intracranial pressure (ICP) can partially explain the Central Nervous System (CNS) impairment due to COVID-19. The ICP waveform can bring relevant information about intracranial compliance, and, nowadays, it can be measured by non-invasive technology. Clinically, non-invasive ICP waveform assessment would help to understand the repercussion of Invasive Mechanical Ventilation (IMV) on CNS in COVID-19 persons. AIMS: This study aims to evaluate the ICP waveform in intubated and non-intubated COVID-19 persons. Furthermore, the association between ICP and IMV parameters, level of sedation, heart rate variability, neurological symptoms, neuroimage, and final discharge will be investigated. . METHODS: At least 30 COVID-19 individuals will be included within 72h from admission and 14 days from symptoms onset. They will be divided into two groups: non-intubated (n=15) and intubated, paired with non-COVID-19 ones (non-intubated and intubated non-COVID-19 groups, respectively). The non-invasive ICP monitoring will be daily performed for 7 consecutive days. The Brain4Care's device and Analytic System will be used to assess the three pulse peaks (P1, 2 and 3) at the ICP waveform. The following variables will be investigated: P1 and P2 amplitude, P2/P1 ratio, time to peak and time percentage of P2 higher than P1. For statistics, all variables will be tested as to their normal or non-normal distribution through appropriate statical analyzes. For basic demographic and clinical variables, descriptive data analysis will be used. The repetitive measurement Anova will be used for ICP outcomes throughout the days. Pearson's or Spearman´s correlations will be applied according to data distribution. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04861402
Study type Observational
Source Federal University of São Paulo
Contact Gisele GS Silva, Sampio
Phone +5511983580583
Email giselesampaio@hotmail.com
Status Recruiting
Phase
Start date April 30, 2020
Completion date December 15, 2021

See also
  Status Clinical Trial Phase
Withdrawn NCT04288076 - The Brain and Lung Interaction (BALI) Study N/A
Recruiting NCT01745081 - Comparison of 20% Mannitol and 3% Hypertonic Saline for Cerebral Relaxation During Elective Supratentorial Craniotomies Phase 4
Recruiting NCT06027567 - The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure Phase 4
Active, not recruiting NCT05068128 - Combined Flow and Pressure Study of Craniospinal Dynamic
Recruiting NCT03087981 - Parameters Analysis in Neurosurgical Critical Patients Through Big Data Acquisition N/A
Withdrawn NCT03933254 - Intraocular Pressure and Optic Nerve Sheath Diameter Changes in Laparoscopic Cholecystectomies
Completed NCT04849221 - Wideband Tympanometry for Monitoring Intracranial Pressure in Adult Patients in Intensive Care, Operated on for an Intracranial Lesion After Traumatic Brain Injury, or With Intracranial Hemorrhage
Recruiting NCT03144297 - Intracranial Pressure vs Percentage Body Fat N/A
Not yet recruiting NCT03853889 - Evaluation of the Effect on Optic Nerve Sheath Diameter in Patients Undergoing Cesarean Section N/A
Not yet recruiting NCT06368648 - CoMind Early Feasibility Study
Recruiting NCT04910087 - The Effect of Anesthesia Management on Optic Nerve Sheath Diameter in the Ercp Procedures N/A
Recruiting NCT03382860 - Estimation of Intracranial Pressure Using Non-invasive Fundus Videos
Completed NCT01330264 - Study of Intracranial Pressure (ICP) Monitoring in Critically Ill N/A
Terminated NCT03938402 - Intraocular Pressure and Optic Nerve Sheath Diameter Changes at Different PEEP Levels N/A
Completed NCT05501613 - Early Multimodal Neuromonitoring For Spontaneous Intracerebral Hemorrhage (ICH)
Completed NCT01685476 - NIMI-NICU: Non Invasive Monitoring of the Intracranial Pressure - NeuroIntensive Care Unit Phase 4
Completed NCT00538616 - Precedex Versus Propofol-Awakening for Reducing Brain Injury Expansion Phase 1/Phase 2
Completed NCT00597831 - Regulation of Intracerebral Pressure During Electroconvulsive Therapy N/A
Terminated NCT00279097 - Safety Study to Evaluate Intracranial Pressure During High Frequency Chest Wall Oscillation N/A
Completed NCT03097523 - Mitigating Cephalad Fluid Shifts: A NSBRI Study N/A